Phase 4Status unknownAge-related condition
Kronos Early Estrogen Prevention Study (KEEPS)
Effects of Estrogen Replacement on Atherosclerosis Progression in Recently Menopausal Women
- Sponsor
- Kronos Longevity Research Institute (Academic or other)
- Enrollment
- 728 planned
- Conditions
- Menopause; Arteriosclerosis
- Interventions
- Conjugated equine estrogens 0.45 mg/day; Transdermal estradiol, 50 mcg/day; Micronized progesterone, 200 mg/day x 12 d/month; CEE , progesterone, estradiol patch or placebo for each; CEE, progesterone, transdermal patch or the placebo
- Ages
- adults
- Registry
- NCT00154180
Full record on ClinicalTrials.gov
From the registry
The study will examine the effects of estrogen and progesterone on the development of atherosclerosis in menopausal women when hormone treatment is initiated within 3 years of the menopausal transition.
Primary outcomes
- Rate of change of carotid intimal medial thickness by ultrasound
History
Study completion
Primary completion
Last registry update
Started
Registered
Papers citing this trial
- Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial
Alzheimer's & dementia : the journal of the Alzheimer's Association
- Associations of blood pressure with white matter hyperintensities later in life; influence of short-term menopausal hormone therapy
Menopause (New York, N.Y.)
- Long-term cognitive effects of menopausal hormone therapy: Findings from the KEEPS Continuation Study
PLoS medicine
- Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy
Maturitas